Inhibiting immune checkpoints is one of the most promising approaches to unleash the potential of the anti-tumor immune response. Immune checkpoint blockades are monoclonal antibodies that bind to checkpoint molecules on the surface of immune and tumor cells. This study presents a comprehensive data set of checkpoint molecules expressed on T cell and tumor cell lines derived from various cancer types that can be used to develop custom immunotherapy screening assays.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.